Evidence map›Paper›PMID 30479669›Full record

ArticleDiabetology & metabolic syndrome2018

Hypoglycemia incidence and awareness among insulin-treated patients with diabetes: the HAT study in Brazil.

Rodrigo Nunes Lamounier, Bruno Geloneze, Silmara Oliveira Leite, Renan Montenegro, Lenita Zajdenverg, Milene Fernandes, Fabiano de Oliveira Griciunas, Mariana Narbot Ermetice, António Roberto Chacra, HAT Brazil study group

Abstract read
In one paragraph

Article in Diabetology & metabolic syndrome, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rodrigo Nunes LamounierCentro de Diabetes de Belo Horizonte, Belo Horizonte, MG Brazil.
Bruno Geloneze2Laboratory of Investigation on Metabolismo and Diabetes (LIMED), University of Campinas-UNICAMP, Campinas, SP Brazil.
Silmara Oliveira LeiteHospital Cruz Vermelha, Curitiba/PR. Centro de Diabetes de Curitiba, Curitiba, PR Brazil.
Renan Montenegro4Faculdade de Medicina da Universidade Federal do Ceará, Fortaleza, CE Brazil.
Lenita Zajdenverg5Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ Brazil.
Milene FernandesEurotrials, Scientific Consultants SA, Lisbon, Portugal.
Fabiano de Oliveira GriciunasNovo Nordisk A/S, São Paulo, SP Brazil.
Mariana Narbot ErmeticeNovo Nordisk A/S, São Paulo, SP Brazil.
António Roberto Chacra8Departamento de Medicina da Universidade Federal de São Paulo-UNIFESP, São Paulo, SP Brazil.
HAT Brazil study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHypoglycemia affects patient safety and glycemic control during insulin treatment of both type 1 (T1DM) and type 2 diabetes mellitus (T2DM). The Hypoglycemia Assessment Tool study in Brazil aimed to determine the proportion of patients experiencing hypoglycemic events and to characterize patient awareness and fear about hypoglycemia, among insulin-treated T1DM or T2DM patients.

methodsThis was a non-interventional, multicenter study, with a 6-month retrospective and a 4-week prospective evaluation of hypoglycemic events. Patients completed a questionnaire at baseline and at the end of the study, and also a patient diary. The answers 'occasionally' and 'never' to the question 'Do you have symptoms when you have a low sugar level?' denoted impaired hypoglycemia awareness. Fear was reported on a 10-point scale, from 'not afraid at all' to 'absolutely terrified'.

resultsFrom 679 included patients, 321 with T1DM and 293 T2DM, median age of 33.0 and 62.0 years, 59% and 56% were female, and median diabetes duration was 15.0 and 15.0 years, respectively. Median time of insulin use was 14.0 and 6.0 years. During the prospective period, 91.7% T1DM and 61.8% T2DM patients had at least one hypoglycemic event. In the same period, 54.0% T1DM and 27.4% T2DM patients had nocturnal hypoglycemia, 20.6% T1DM and 10.6% T2DM patients had asymptomatic hypoglycemia, and severe events occurred in 20.0% and 10.3%, respectively. At baseline, 21.4% T1DM and 34.3% T2DM had hypoglycemia unawareness. The mean score of hypoglycemia fear was 5.9 ± 3.1 in T1DM and 5.4 ± 3.9 in T2DM. The most common attitude after hypoglycemic events were to increase calorie intake (60.3%) and blood glucose monitoring (58.0%) and to reduce or skip insulin doses (30.8%).

conclusionsReferred episodes of hypoglycemia were high, in both T1DM and T2DM insulin users. Patient attitudes after hypoglycemia, such as reduction in insulin and increase in calorie intake, can affect diabetes management. These findings may support clinicians in tailoring diabetes education and insulin treatment for patients with diabetes, in order to improve their glycemic control while reducing the risk of hypoglycemic events.

Indexed as

Diabetes mellitus type 1Diabetes mellitus type 2HypoglycemiaInsulin therapy

Identifiers

PMID30479669
PMCPMC6249957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.